Biologic Patent Transparency Act

United States116e CongrèsHR-4850House of Representatives
Mis à jour : 18 déc. 2019

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Introduced (House)Consulter le texte officiel

1 version disponible

Tous les dossiers disponibles sont affichés.

Chronologie

Dernière mesure du projet de loi complémentaire

S-659: Biologic Patent Transparency Act

Introduced in Senate

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

    House of Representatives

Tous les dossiers disponibles sont affichés.